产品特点
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Name of the product in FR: Cobactan DC
Name of the product in UK/IE: Cephaguard DC 150 mg intramammary ointment
All other CMS: Cobactan DC 150 mg intramammary ointment
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 3 g pre-filled syringe contains:
ACTIVE SUBSTANCE
Cefquinome (as sulphate): 150.0 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary ointment
Homogeneous off-white oily ointment
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (dry cows)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of subclinical mastitis at drying off and the prevention of new bacterial
infections of the udder during the dry period in the dairy cow caused by the following
cefquinome sensitive organisms: _Streptococcus uberis, Streptococcus dysgalactiae, _
_Streptococcus agalactiae, Staphylococcus aureus, _coagulase negative staphylococci.
4.3
CONTRAINDICATIONS
Not to be administered to animals which are known to be hypersensitive to cephalosporin
antibiotics or other β-lactam antibiotics.
Not to be administered to cows with clinical mastitis.
And see section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
USE OF THE PRODUCT SHOULD BE BASED ON SUSCEPTIBILITY TESTING OF THE BACTERIA ISOLATED FROM THE
ANIMAL. IF IT IS NOT POSSIBLE, THERAPY SHOULD BE BASED ON LOCAL (REGIONAL, FARM LEVEL)
EPIDEMIOLOGICAL INFORMATION ABOUT SUSCEPTIBILITY OF THE TARGET BACTERIA
Do not use
阅读完整的文件